Objectives of the Project
The goal for all people with inflammatory rheumatic disease is to live a normal life without limitation in daily live. This includes family planning and having children. There is a high unmet need of robust data on the outcomes of pregnancies and on the safety of a substantial number of drugs when used before or during pregnancy.
Currently, three registers in Europe collect prospective data on pregnancies in women with inflammatory rheumatic diseases and one register is about to start.
The primary outcome is the definition of a core data set. Secondary, a first joint data analysis and publication on pregnancy outcomes in e.g. Rheumatoid Arthritis broken down by risk factors and exposures will be performed.